Medicare Enrolled

Dr. Abdalla Sholi, MD

Hematology & Oncology · Williamsport, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1100 GRAMPIAN BLVD, Williamsport, PA 17701
5703268470
In practice since 2005 (20 years)
NPI: 1275523052 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sholi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sholi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sholi

Dr. Abdalla Sholi is a hematology & oncology specialist in Williamsport, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sholi performed 1,322 Medicare services across 577 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sholi received a total of $495,277 from 55 pharmaceutical and/or device companies across 821 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sholi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 23% volume in PA $495,277 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,322
Medicare services
Top 23% in PA for hematology & oncology
577
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~66 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
1,098 $103 $308
New patient office visit, complex (60-74 min) 90 $129 $445
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
89 $69 $234
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $89 $350
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $42 $157
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
13 $100 $306
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$495,277
Total received (2018-2024)
Avg $70,754/year across 7 years
Top 2% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
821
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$446,205 (90.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$35,239 (7.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,834 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$136,840
2023
$113,949
2022
$81,711
2021
$39,416
2020
$21,351
2019
$49,943
2018
$52,067

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$47,412
GlaxoSmithKline, LLC.
$39,771
JAZZ PHARMACEUTICALS INC.
$17,650
Incyte Corporation
$17,302
SOBI, INC
$10,446
Janssen Scientific Affairs, LLC
$1,323
Janssen Biotech, Inc.
$590
Gilead Sciences, Inc.
$168
Amgen Inc.
$161
Novartis Pharmaceuticals Corporation
$154
Stemline Therapeutics Inc.
$134
Mirati Therapeutics, Inc.
$125
GENZYME CORPORATION
$125
E.R. Squibb & Sons, L.L.C.
$125
Janssen Pharmaceuticals, Inc
$125
Astellas Pharma US Inc
$125
Takeda Pharmaceuticals U.S.A., Inc.
$124
Merck Sharp & Dohme LLC
$118
PFIZER INC.
$118
Genmab U.S., Inc.
$110
Alexion Pharmaceuticals, Inc.
$99
BeiGene USA, Inc.
$90
SEAGEN INC.
$90
Novocure Inc.
$83
Lilly USA, LLC
$74
Daiichi Sankyo Inc.
$71
Myriad Genetic Laboratories, Inc.
$64
Tempus AI, Inc
$63
Top 3 companies account for 76.6% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$172,768
AstraZeneca Pharmaceuticals LP
$118,892
GlaxoSmithKline, LLC.
$96,816
JAZZ PHARMACEUTICALS INC.
$17,912
PFIZER INC.
$13,769
Daiichi Sankyo Inc.
$13,514
SOBI, INC
$10,446
Gilead Sciences, Inc.
$9,510
CTI BioPharma Corp.
$9,336
Novocure Inc.
$5,568
E.R. Squibb & Sons, L.L.C.
$5,122
Celgene Corporation
$4,383
Janssen Biotech, Inc.
$3,391
Janssen Scientific Affairs, LLC
$2,945
Exelixis Inc.
$1,704
Novartis Pharmaceuticals Corporation
$1,240
Genentech USA, Inc.
$792
GENZYME CORPORATION
$762
Pharmacyclics LLC, An AbbVie Company
$657
Alexion Pharmaceuticals, Inc.
$538
BeiGene USA, Inc.
$450
Takeda Pharmaceuticals U.S.A., Inc.
$404
Amgen Inc.
$358
Stemline Therapeutics Inc.
$325
Lilly USA, LLC
$280
Mirati Therapeutics, Inc.
$251
Merck Sharp & Dohme Corporation
$235
Seattle Genetics, Inc.
$231
Bayer HealthCare Pharmaceuticals Inc.
$225
Seagen Inc.
$219
Pharmacyclics LLC, an AbbVie Company
$214
Janssen Pharmaceuticals, Inc
$177
Astellas Pharma US Inc
$143
Kyowa Kirin, Inc.
$131
Teva Pharmaceuticals USA, Inc.
$127
Merck Sharp & Dohme LLC
$118
Teleflex LLC
$118
Eisai Inc.
$116
Genmab U.S., Inc.
$110
Ipsen Biopharmaceuticals, Inc
$101
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$99
Pharmacosmos Therapeutics Inc.
$96
Dova Pharmaceuticals
$93
SEAGEN INC.
$90
AbbVie Inc.
$78
Myriad Genetic Laboratories, Inc.
$64
Tempus AI, Inc
$63
Sumitomo Pharma America, Inc.
$63
Taiho Oncology, Inc.
$60
Regeneron Healthcare Solutions, Inc.
$40
Clovis Oncology, Inc.
$38
GE HealthCare
$34
Helsinn Therapeutics (U.S.), Inc.
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Spectrum Pharmaceuticals Inc.
$14
Top 3 companies account for 78.4% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ARROW · Abraxane · Alecensa · Avastin · BALVERSA · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · Cabometyx · DARZALEX · Doptelet · ELIQUIS · ELZONRIS · EMEND · EMPLICITI · ENHERTU · ERLEADA · Enhertu · Epkinly · Erleada · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMDELLTRA (AMG 757) · IMFINZI · INVOKANA · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LORBRENA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NINLARO · Nplate · OJJAARA · ONIVYDE · OPDIVO · OPTUNE LUA (NOVOTTF-200T) · ORGOVYX · OnControl Bone Marrow Biopsy Trays · Optune · Orserdu · POTELIGEO · PROMACTA · Perjeta · Pomalyst · Prolia · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Trodelvy · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vonjo · XALKORI · XARELTO · XGEVA · XIFAXAN · XTANDI · Xofigo · Xtandi · ZEJULA · ZEPZELCA · ZIIHERA · ZYTIGA · Zevalin · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for hematology & oncology in PA.

Looking for a hematology & oncology specialist in Williamsport?
Compare hematology & oncology specialists in the Williamsport area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
5
Per 100K population
4.4
County median income
$64,412
Nearest hospital
UPMC WILLIAMSPORT
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sholi is a clinical cardiology specialist, with above-average Medicare volume (top 23% in PA), with speaking/promotional industry engagement in the top 2% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sholi experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Sholi performed 1,098 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sholi receive payments from pharmaceutical companies?
Yes. Dr. Sholi received a total of $495,277 from 55 companies across 821 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sholi's costs compare to other hematology & oncology specialists in Williamsport?
Dr. Sholi's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sholi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →